LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. will hold its 2025 annual general meeting (AGM) on 22 May 2026 in Shanghai to vote on 11 key resolutions covering operating reports, capital allocation, governance changes and fresh share authorities.

Dividend Proposal • The Board proposes a final cash dividend of RMB 0.50 per share for FY 2025, equating to an aggregate RMB 173.40 million. • Record date: 2 June 2026; book closure: 29 May–2 June 2026. • Payment is targeted on or before 31 July 2026. Dividends for southbound trading investors will be settled in renminbi; Hong Kong holders will receive Hong Kong dollars based on the PBOC five-day average rate preceding the AGM.

Operational & Financial Highlights • FY 2025 results and independent auditor’s report will be tabled for approval. • The 2026 financial budget earmarks RMB 120.00 million for R&D—mainly new occluder and heart-valve projects—and RMB 20.00 million for property, plant and equipment.

Board & Supervisory Matters • Re-appointment of BDO China Shu Lun Pan as external auditor for 2026 at an estimated fee of RMB 1.35 million. • Ratification of 2025 director and supervisor remuneration and approval of the 2026 remuneration framework. • Election of Ms Wang Yong, currently CFO and senior deputy GM of parent company Lepu Medical, as supervisor and chair of the second Board of Supervisors; her tenure aligns with the current supervisory term and she will receive no remuneration from LEPU ScienTech.

Capital Management Authorities • Share Issue Mandate: Board may issue, allot or transfer up to 20% of issued shares—capped at 69.35 million shares—during the 12 months following approval, subject to regulatory clearances. • Share Repurchase Mandate: Board may buy back up to 10% of issued H shares—up to 34.67 million shares—within the same period, with repurchased shares to be cancelled or held as treasury stock for future use in employee incentive plans or other purposes compliant with listing rules. • Any share buy-backs will be funded from internal resources and must not impair working-capital adequacy.

Meeting Logistics • Shareholders registered by 18 May 2026 are eligible to attend and vote. • Proxy forms must reach Tricor Investor Services (HK) no later than 24 hours before the meeting. • All resolutions will be decided by poll in accordance with Hong Kong Listing Rules.

The Board recommends shareholders approve all proposed resolutions at the upcoming AGM.